However, since fenofibrate treatment reduced islet size and decreased insulin-secreting β-cell areas in HFD mice to levels similar to those in LFD mice, normalization of β-cell mass by fenofibrate is likely to lower circulating insulin levels and suppress insulin resistance during obesity in OVX mice. The gene discussed is INS; the disease is Obesity.